This inventor holds 2 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignees: The University of Texas System, US Government as Represented by the Secretary of the Army. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2025
Title: Ziding Feng: Innovator in Lung Cancer Detection and Treatment
Introduction
Ziding Feng is a prominent inventor based in Houston, Texas, known for his significant contributions to the field of medical technology. His work primarily focuses on the detection and treatment of lung cancer, a critical area of research that has the potential to save countless lives. With a strong academic background and a commitment to innovation, Feng has made strides in developing methods that enhance early detection of this disease.
Latest Patents
Ziding Feng holds a patent titled "Methods for the detection and treatment of lung cancer." This patent provides methods and related kits for the detection of early-stage lung cancer, as well as determining the risk of harboring lung cancer. His innovative approach aims to improve diagnostic accuracy and facilitate timely intervention for patients.
Career Highlights
Feng is affiliated with the University of Texas System, where he conducts research and collaborates with other experts in the field. His work has garnered attention for its potential impact on lung cancer diagnosis and treatment, making him a valuable asset to the medical research community.
Collaborations
Ziding Feng has collaborated with notable colleagues, including Samir Hanash and Ayumu Taguchi. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in cancer research.
Conclusion
Ziding Feng's contributions to lung cancer detection and treatment exemplify the importance of innovation in medical research. His patent and ongoing work at the University of Texas System highlight his dedication to improving patient outcomes through early detection methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile